viernes, 24 de noviembre de 2017

Prostate Cancer - Nov 23, 2017 Edition

 
 November 23, 2017 
 Prostate Cancer 
 The latest prostate cancer news from News Medical 
 Common genetic fusion event could help identify patients with low-risk prostate cancerCommon genetic fusion event could help identify patients with low-risk prostate cancer
 
Establishing the way in which a genetic alteration called a TMPRSS2-ERG gene fusion forms in a prostate cancer, rather than the presence of the gene fusion itself, could help identify patients with prostate cancer with a low risk of spreading, which might determine the best course of treatment for the patient.
 
 
 Small protein modification can trigger invasive properties of prostate cancer cells, research findsSmall protein modification can trigger invasive properties of prostate cancer cells, research finds
 
A small protein modification can trigger the aggressive migratory and invasive properties of prostate cancer cells, according to new research published on the cover of Oncotarget. The findings give greater insight into how cancers can move from one location in the body to another, and could help develop more effective therapies in the future.
 
   Anti-parasite drug acts like tailored medicine against colon, prostate cancerAnti-parasite drug acts like tailored medicine against colon, prostate cancer
 
Medicine against parasites like Tapeworms and Giardia, contains a substance that kills Prostate- and colon cancer.
 
   Use of Prostate Health Index cuts down need for uncomfortable biopsiesUse of Prostate Health Index cuts down need for uncomfortable biopsies
 
The Prostate Health Index is a cost-effective tool used by urologists to detect prostate cancer. It reduces the risk of over diagnosis, and cuts down on the need to send men for unnecessary and often uncomfortable biopsies.
 
 UVA researchers developing new tool to help cancer patients make complex care decisions
 
UVA researchers developing new tool to help cancer patients make complex care decisionsResearchers at the University of Virginia Cancer Center are developing a tool to help patients with prostate cancer better understand the potential risks and rewards of their treatment options. And that tool could ultimately benefit not just those patients but a broad spectrum of patients making complex care decisions based on their tumor's genomic information.
 
 
 Novel AR glasses help doctors to locate lymph nodes during surgery
 
Novel AR glasses help doctors to locate lymph nodes during surgeryMalignant tumors often form metastases that spread to other parts of the body via the lymphatic system. High surgical skills are required to identify the precise location of the affected lymph nodes, enabling them to be completely removed.
 

No hay comentarios:

Publicar un comentario